Skip to main content
Home

Our Solutions

At Chiesi, our responsibility goes beyond developing medicines. We act as a force for good – using science, partnerships and our voice to help create healthier, more fulfilling lives for people today and for generations to come.  

We work to make care easier to navigate, more sustainable, and more responsive to the people it is designed to support. Because, behind every diagnosis is a person with loved ones, ambitions, and everyday challenges that deserve understanding.

We know that we cannot do this alone. Every therapeutic research program, partnership, and clinical innovation begins with listening. We work closely with patient communities, healthcare professionals, researchers, and decision-makers to understand what care truly means in everyday life, and where support is most needed.  

Respiratory  

Advancing respiratory care, one breath at a time 

Our ambition is to innovate how medicines for asthma, chronic obstructive pulmonary disease (COPD), and other chronic respiratory diseases are made and delivered for the health of people, and the health of our planet.

Rare Diseases 

Driving innovation and access for people living with genetically inherited rare diseases  

Our ambition is to give as many people living with a rare or ultra-rare disease as possible better access to innovative treatment, care, and a chance at a fuller life. By listening to and partnering with voices of the rare disease community, we want to become a recognized point of reference. 

Specialty Care 

Supporting patients, caregivers, and healthcare professionals through life’s most critical moments and everyday health journeys

Our ambition across Neonatology, Transplants, and Consumer Healthcare is to combine science and empathy to deliver specialist solutions that go beyond medicine. Because true care is not just about treatment, it is about supporting people at every stage of their journey. 

Our Pipeline

Our research pipeline spans respiratory health, rare diseases and specialty care, with a clear strategic focus on advancing science and technologies that address patients’ most urgent needs.

Across all our therapy areas, we invest consistently and at scale to turn scientific insight into meaningful progress. In 2024, Chiesi reinvested 24.3% of its revenue into Research & Development, reflecting our long-term commitment to innovation. 

Our Clinical Trials

The patient voice is embedded in our research processes, and we strive to design studies that respond to real needs and communicate clearly and respectfully.

Our clinical trials translate scientific understanding into progress for the future; across respiratory, rare, and specialty care, we conduct research with scientific excellence and deep respect for every person who participates.